Blogs Categories: Cultivo Innovaciones Economia Noticias
El extracto de cannabis ha demostrado ser efectivo en la lucha contra el cáncer de piel (melanoma)

A new wave of research shines a promising light on cannabis and its compounds, suggesting their potential to curb the spread and severity of COVID-19 infections. Furthermore, they could play a crucial role in managing long COVID symptoms, including mental health challenges and appetite loss. Researchers at Dalhousie University in Canada meticulously reviewed existing scientific literature, unearthing intriguing findings about marijuana as a preventive and therapeutic aid, as detailed in the Journal of Clinical Medicine.

Cannabis compounds, particularly cannabinoids, are highlighted for their ability to block the virus's entry, reduce oxidative stress, and soothe the intense immune response known as the "cytokine storm," which is a hallmark of early COVID-19 infections. Following the battle with the virus, cannabinoids have been observed to ease post-COVID conditions like depression, anxiety, PTSD, insomnia, pain, and decreased appetite, showcasing a beacon of hope for long COVID sufferers.

The research underscores a concerted effort to bridge the knowledge gap regarding the endocannabinoid system (ECS) and its modulation in both the early and post-infection stages of COVID-19. While cannabis has been considered for treatment during the acute phase, this study broadens the perspective, suggesting a potential role in prevention and long-term recovery.

El extracto de cannabis ha demostrado ser efectivo en la lucha contra el cáncer de piel (melanoma)

Despite the optimism, the study acknowledges certain limitations, such as the variance in cannabis products and the different effects of cannabinoids on adults versus youth. Moreover, the bulk of ECS-related research predates COVID-19, urging cautious interpretation when applying these findings to the current pandemic.

The call for further investigation is clear, with the authors advocating for clinical trials and rigorous studies to unravel the mechanisms, ideal dosages, and safety profiles of cannabinoid-based treatments in the context of COVID-19. Such comprehensive understanding is pivotal to harnessing the therapeutic capabilities of cannabis against the virus and the lingering aftermath of long COVID.

In sum, while the path to definitive answers is lined with questions and caution, the potential of cannabis as a dual force against COVID-19 and its prolonged effects offers a glimmer of hope in the ongoing health crisis.

Follow us on Instagram, there's even more interesting stuff there.

Comments (0)

No comments at this moment

New comment

Product added to compare.

Programa Kit Digital financiado por los fondos Next Generation del mecanismo de recuperación y resiliencia